CNAF News Alert Commercial National Financial Corp. (CNAF) 21.7000

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Commercial National Financial Corp. (CNAF) 21.7000 $CNAF

Commercial National Financial declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 2:00PM CST


Commercial National Declares $0.26 Per Share Fourth Quarter Dividend
PR Newswire - Tue Nov 18, 1:48PM CST
Commercial National Financial Corporation (OTCQB-CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable December 5 to shareholders of record as of November 28.

Commercial National Shares Commence Trading On OTCQX Marketplace
PR Newswire - Wed Sep 24, 6:00AM CDT
Commercial National Financial Corporation (OTCQX: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.

OTC Markets Group Welcomes Commercial National Financial Corporation to OTCQX®
PR Newswire - Wed Sep 24, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Commercial National Financial Corporation (OTCQX: CNAF), parent company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.

Commercial National Declares $0.26 Per Share Third Quarter Dividend
PR Newswire - Tue Aug 19, 3:54PM CDT
Commercial National Financial Corporation (OTCQB: CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable September 5 to shareholders of record as of August 29.

Commercial National Reports 22.78% Second Quarter And 33.39% First Six Months 2014 Earnings Growth
PR Newswire - Mon Jul 28, 10:05AM CDT
Commercial National Financial Corporation (OTC Markets: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has reported results for the quarter ended June 30, 2014. The Company earned $1,655,000 (or $0.58 per average share outstanding) in the second quarter 2014 compared to $1,348,000 (or $0.47 per average share outstanding) in the second quarter 2013. The Company earned $3,268,000 (or $1.14 per average share outstanding) for the six-month period ended June 30, 2014 and $2,450,000 (or $0.86 per average share outstanding) for the six-month period ended June 30, 2013. The Company's annualized return on average assets and average equity were 1.66% and 12.55%, respectively, for the quarter ended June 30, 2014 compared to 1.44% and 10.30%, respectively, for the quarter ended June 30, 2013. The Company's annualized return on average assets and average equity for the six month period ended June 30, 2014 were 1.65% and 12.39%, respectively, compared to 1.30% and 9.32%, respectively, for the six month period ended June 30, 2013. Tier one risk-based, total risk-based and leverage capital ratios for June 30, 2014 were 22.04%, 22.74% and 12.87%, respectively.

Pharmaceutical Executive, Rick Burch named President of Innovative Med Concepts, LLC
PR Newswire - Wed Feb 19, 9:53AM CST
Mr. Burch joins Innovative Med Concepts, LLC (IMC); a Biotech company based in Tuscaloosa, AL, following his most recent role as V.P. and General Manager of the CNS Business Unit for UCB, a global biopharma company based in Brussels. Prior to UCB, he had a 30-year career with pharmaceutical giant Pfizer, starting as a sales rep and working his way up to Senior Vice President overseeing several divisions as large as 6,500 people and $11.5 billion in revenue. Mr. Burch has launched over 20 pharmaceutical products with accountability for many "blockbuster" brands such as Celebrex, Lyrica, Aricept, Lipitor and Vimpat.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading